<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>The Evolution of Prostate Cancer: A Prognostic Infographic</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Roboto+Condensed:wght@400;700&family=Roboto:wght@400;500;700&display=swap" rel="stylesheet">
    <style>
        :root {
            --stage-1-color: #7dd3fc; /* sky-300 */
            --stage-2-color: #67e8f9; /* cyan-300 */
            --stage-3-color: #fca5a5; /* red-300 */
            --stage-4-color: #f87171; /* red-400 */
            --stage-5-color: #ef4444; /* red-500 */
            --stage-6-color: #b91c1c; /* red-700 */
        }
        body {
            font-family: 'Roboto', sans-serif;
            background-color: #f8fafc;
            color: #334155;
            -webkit-print-color-adjust: exact;
        }
        .infographic-container {
            width: 100%;
            max-width: 1600px;
            margin: 1rem auto;
            padding: 2rem;
            position: relative;
        }
        h1, h2, h3 {
            font-family: 'Roboto Condensed', sans-serif;
            font-weight: 700;
            color: #1e293b;
        }
        .stage-row-grid {
            display: grid;
            grid-template-columns: 2.5fr 1fr 9fr; /* Adjusted for more space for stage titles */
            gap: 1.5rem;
            align-items: stretch;
        }
        .timeline-cell {
            position: relative;
            display: flex;
            justify-content: center;
            align-items: center;
        }
        .timeline-cell::before, .timeline-cell::after {
            content: '';
            position: absolute;
            left: 50%;
            transform: translateX(-50%);
            width: 4px;
            background: #d1d5db;
            z-index: 1;
        }
        .timeline-cell::before { top: 0; bottom: 50%; margin-bottom: 12px; }
        .timeline-cell::after { top: 50%; bottom: 0; margin-top: 12px; }
        .stage-row:first-child .timeline-cell::before { display: none; }
        .stage-row:last-child .timeline-cell::after { display: none; }
        .timeline-dot {
            width: 24px;
            height: 24px;
            border-radius: 50%;
            border: 4px solid white;
            z-index: 2;
            position: relative;
            box-shadow: 0 0 0 4px;
        }
        .stage-card {
            text-align: right;
            position: relative;
            display: flex;
            flex-direction: column;
            justify-content: center;
        }
        .stage-card h3 { font-size: 1.4rem; line-height: 1.3; } /* Increased size */
        .stage-card p { font-size: 1.1rem; color: #64748b; } /* Increased size */
        .findings-grid {
            display: grid;
            grid-template-columns: repeat(5, 1fr);
            gap: 1rem;
        }
        .modality-header {
            text-align: center;
            font-size: 1.1rem; /* Increased size */
            font-weight: 700;
            color: #475569;
            display: flex;
            align-items: center;
            justify-content: center;
            gap: 0.5rem;
        }
        .finding-card {
            background-color: #ffffff;
            border-radius: 0.5rem;
            padding: 0.8rem;
            font-size: 1.05rem; /* Increased size */
            line-height: 1.5;
            border-left: 4px solid;
            box-shadow: 0 1px 2px 0 rgb(0 0 0 / 0.05);
        }
    </style>
</head>
<body class="bg-slate-50">

    <div class="infographic-container">
        <header class="text-center mb-8">
            <h1 class="text-4xl font-bold text-slate-800">Diagnostic Manifestations of Prostate Cancer Evolution</h1>
        </header>

        <!-- Headers for the findings columns -->
        <div class="stage-row-grid mb-4">
            <div class="col-start-3">
                <div class="findings-grid">
                    <div class="modality-header"><svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" viewBox="0 0 20 20" fill="currentColor"><path fill-rule="evenodd" d="M10 9a3 3 0 100-6 3 3 0 000 6zm-7 9a7 7 0 1114 0H3z" clip-rule="evenodd" /></svg>Clinical & Lab</div>
                    <div class="modality-header"><svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" viewBox="0 0 20 20" fill="currentColor"><path d="M5 3a2 2 0 00-2 2v2a2 2 0 002 2h2a2 2 0 002-2V5a2 2 0 00-2-2H5zM5 11a2 2 0 00-2 2v2a2 2 0 002 2h2a2 2 0 002-2v-2a2 2 0 00-2-2H5zM11 5a2 2 0 012-2h2a2 2 0 012 2v2a2 2 0 01-2 2h-2a2 2 0 01-2-2V5zM11 13a2 2 0 012-2h2a2 2 0 012 2v2a2 2 0 01-2 2h-2a2 2 0 01-2-2v-2z" /></svg>CT</div>
                    <div class="modality-header"><svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" viewBox="0 0 20 20" fill="currentColor"><path fill-rule="evenodd" d="M11.3 1.046A1 1 0 0112 2v5h4a1 1 0 01.82 1.573l-7 10A1 1 0 018 18v-5H4a1 1 0 01-.82-1.573l7-10a1 1 0 011.12-.38z" clip-rule="evenodd" /></svg>MRI</div>
                    <div class="modality-header"><svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" viewBox="0 0 20 20" fill="currentColor"><path fill-rule="evenodd" d="M5.05 3.636a1 1 0 011.414 0L10 7.172l3.536-3.536a1 1 0 111.414 1.414L11.414 8.586l3.536 3.536a1 1 0 11-1.414 1.414L10 9.999l-3.536 3.536a1 1 0 01-1.414-1.414L8.586 8.586 5.05 5.05a1 1 0 010-1.414z" clip-rule="evenodd" /></svg>PSMA-PET</div>
                    <div class="modality-header"><svg xmlns="http://www.w3.org/2000/svg" class="h-6 w-6" viewBox="0 0 20 20" fill="currentColor"><path d="M15 4a3 3 0 11-6 0 3 3 0 016 0zM12 2a5 5 0 00-5 5c0 1.284.483 2.45 1.285 3.356L3.11 18.53A1.5 1.5 0 004.225 20h11.55a1.5 1.5 0 001.115-2.47l-5.175-8.174A4.978 4.978 0 0017 7a5 5 0 00-5-5z" /></svg>Histopathology</div>
                </div>
            </div>
        </div>

        <div class="stages-container space-y-8">
            <!-- STAGE 1 ROW -->
            <div class="stage-row stage-row-grid">
                <div class="stage-card"><h3>Risk Factors & Premalignant</h3><p>Cellular changes driven by risk</p></div>
                <div class="timeline-cell"><div class="timeline-dot" style="background-color: var(--stage-1-color); box-shadow: 0 0 0 4px var(--stage-1-color);"></div></div>
                <div class="findings-grid">
                    <div class="finding-card" style="border-color: var(--stage-1-color);"><strong>Asymptomatic.</strong> Risk factors (age, family history). Baseline PSA.</div>
                    <div class="finding-card" style="border-color: var(--stage-1-color);">No tumor visible. Can quantify systemic risks (fat, sarcopenia).</div>
                    <div class="finding-card" style="border-color: var(--stage-1-color);">Not used for risk factors. May show benign changes like BPH.</div>
                    <div class="finding-card" style="border-color: var(--stage-1-color);">Not indicated. No PSMA expression.</div>
                    <div class="finding-card" style="border-color: var(--stage-1-color);">Biopsy may show precursors (HGPIN, ASAP).</div>
                </div>
            </div>
            <!-- STAGE 2 ROW -->
            <div class="stage-row stage-row-grid">
                <div class="stage-card"><h3>Organ-Confined Disease</h3><p>Cancer (T1/T2) in prostate</p></div>
                <div class="timeline-cell"><div class="timeline-dot" style="background-color: var(--stage-2-color); box-shadow: 0 0 0 4px var(--stage-2-color);"></div></div>
                <div class="findings-grid">
                    <div class="finding-card" style="border-color: var(--stage-2-color);">Asymptomatic, but elevated PSA. Post-RP, PSA should be zero.</div>
                    <div class="finding-card" style="border-color: var(--stage-2-color);">Cannot visualize organ-confined tumors. No role in local staging.</div>
                    <div class="finding-card" style="border-color: var(--stage-2-color);"><strong>Standard for detection:</strong> low T2 signal, low ADC, early enhancement.</div>
                    <div class="finding-card" style="border-color: var(--stage-2-color);">Visualizes primary tumor. High SUVmax/PSMA-TV suggests aggressiveness.</div>
                    <div class="finding-card" style="border-color: var(--stage-2-color);"><strong>Definitive diagnosis</strong> via biopsy (adenocarcinoma, Gleason Score).</div>
                </div>
            </div>
            <!-- STAGE 3 ROW -->
            <div class="stage-row stage-row-grid">
                <div class="stage-card"><h3>Aggressive Histology</h3><p>Transition to high-grade</p></div>
                <div class="timeline-cell"><div class="timeline-dot" style="background-color: var(--stage-3-color); box-shadow: 0 0 0 4px var(--stage-3-color);"></div></div>
                <div class="findings-grid">
                    <div class="finding-card" style="border-color: var(--stage-3-color);">No unique symptoms. High PSA, rapid kinetics (short PSADT).</div>
                    <div class="finding-card" style="border-color: var(--stage-3-color);">Not visible. CT Perfusion may show high Blood Flow (angiogenesis).</div>
                    <div class="finding-card" style="border-color: var(--stage-3-color);">Lower ADC values. Radiomics can quantify heterogeneity (cribriform).</div>
                    <div class="finding-card" style="border-color: var(--stage-3-color);">High PSMA-TV on staging predicts cribriform/LVI.</div>
                    <div class="finding-card" style="border-color: var(--stage-3-color);"><strong>Gold Standard:</strong> visualization of cribriform/IDC-P (Gleason 4).</div>
                </div>
            </div>
            <!-- STAGE 4 ROW -->
            <div class="stage-row stage-row-grid">
                <div class="stage-card"><h3>Local Invasion</h3><p>Extracapsular Extension (T3/T4)</p></div>
                <div class="timeline-cell"><div class="timeline-dot" style="background-color: var(--stage-4-color); box-shadow: 0 0 0 4px var(--stage-4-color);"></div></div>
                <div class="findings-grid">
                    <div class="finding-card" style="border-color: var(--stage-4-color);">Local symptoms (urinary/erectile). Rising PSA, short PSADT.</div>
                    <div class="finding-card" style="border-color: var(--stage-4-color);">Low sensitivity for micro ECE. Can show gross extension (T3/T4).</div>
                    <div class="finding-card" style="border-color: var(--stage-4-color);"><strong>Crucial for staging:</strong> shows capsular disruption, SVI.</div>
                    <div class="finding-card" style="border-color: var(--stage-4-color);">Detects PSMA-avid foci beyond capsule, improving ECE/SVI staging.</div>
                    <div class="finding-card" style="border-color: var(--stage-4-color);"><strong>Definitive via RP:</strong> confirms ECE or SVI microscopically.</div>
                </div>
            </div>
            <!-- STAGE 5 ROW -->
            <div class="stage-row stage-row-grid">
                <div class="stage-card"><h3>Regional Spread</h3><p>Lymph Node Metastasis (N1)</p></div>
                <div class="timeline-cell"><div class="timeline-dot" style="background-color: var(--stage-5-color); box-shadow: 0 0 0 4px var(--stage-5-color);"></div></div>
                <div class="findings-grid">
                    <div class="finding-card" style="border-color: var(--stage-5-color);">Asymptomatic. Main sign is BCR (rising PSA post-therapy).</div>
                    <div class="finding-card" style="border-color: var(--stage-5-color);">Low sensitivity N-staging; relies on size (>1cm), misses micro-mets.</div>
                    <div class="finding-card" style="border-color: var(--stage-5-color);">Better than CT; uses size, shape, low ADC. Still limited.</div>
                    <div class="finding-card" style="border-color: var(--stage-5-color);"><strong>New Gold Standard:</strong> high accuracy for small nodes via molecular signature.</div>
                    <div class="finding-card" style="border-color: var(--stage-5-color);"><strong>Definitive via histology:</strong> confirms positive nodes and ENE.</div>
                </div>
            </div>
            <!-- STAGE 6 ROW -->
            <div class="stage-row stage-row-grid">
                <div class="stage-card"><h3>Distant Dissemination</h3><p>Bone Metastasis (M1b)</p></div>
                <div class="timeline-cell"><div class="timeline-dot" style="background-color: var(--stage-6-color); box-shadow: 0 0 0 4px var(--stage-6-color);"></div></div>
                <div class="findings-grid">
                    <div class="finding-card" style="border-color: var(--stage-6-color);">Symptomatic (bone pain). Elevated AP, anemia, detectable CTCs.</div>
                    <div class="finding-card" style="border-color: var(--stage-6-color);">Excellent for visualizing osteoblastic lesions and fracture risk.</div>
                    <div class="finding-card" style="border-color: var(--stage-6-color);">Highly sensitive for early detection (marrow replacement).</div>
                    <div class="finding-card" style="border-color: var(--stage-6-color);">More sensitive than bone scan; quantifies total tumor burden.</div>
                    <div class="finding-card" style="border-color: var(--stage-6-color);">Bone biopsy confirms mets, but not always needed if imaging is clear.</div>
                </div>
            </div>
        </div>
    </div>
</body>
</html>